Postoperative prevention of chronic kidney disease in patients with renal cell Carcinoma

Authors

  • S. М. Pasichnyk Danylo Halytsky Lviv National Medical University
  • М. S. Pasichnyk Danylo Halytsky Lviv National Medical University
  • О. B. Leschuk Lviv Regional Clinical Hospital
  • А. І. Gozhenko Ukrainian Research Institute of Transport Medicine, Оdesa

DOI:

https://doi.org/10.11603/2414-4533.2020.3.11465

Keywords:

renal cell carcinoma, chronic kidney disease, arterial hypertension

Abstract

The aim of the work: to investigate the effect on renal function in patients with renal cell carcinoma (RCC) as ACE inhibitors (perindopril arginine) monotherapy and in combination with Ca-channel blockers in the treatment of concomitant arterial hypertension.

Materials and Methods. The study involved 38 patients with RCC. All patients were diagnosed with RCC for the first time, according to the International Classification of TNM (T1 N0 M0). Group 1 included 17 patients. In addition to the above-mentioned surgical treatment, a combination of ACE inhibitors (perindopril arginine 5 mg) and Ca-channel blockers (amlodipine 5 mg) Bi-prestrium was used to treat arterial hypertension in all patients of group I. Group 2 included 21 patients who, in contrast to group I patients, were treated with ACE inhibitors (perindopril arginine 5 mg) for the treatment of arterial hypertension.

Results and Discussion. As a result of the treatment, during 3 months of follow-up, in both groups of the study there was a statistically significant decrease in the mean values ​​of systolic and diastolic blood pressure to normal values. As a result of the study, during 3 months of follow-up, in patients of group II of the study there was a statistically significant increase in mean values ​​of serum creatinine and an increase in GFR compared with patients in group I.

References

Shalnova, S.А. (2003). Problemy lecheniya arterialnoy gipertonii [Problems in the treatment of arterial hypertension]. Kardiovaskulyarnaya terapiya i profilaktika – Cardiovascular Therapy and Prevention, 3, 17-21 [in Russian].

Lopatin, М.Yu. (2001). Problemy s dozirovanoy fisicheskoy nagruzkoy (veloergometriya, tredmil – test). Nauchno-prakticheskie rekomendatsii [Samples with dosed physical activity (bicycle ergometry, treadmill test): scientific and practical recommendations]. Volgograd: VOKTs [in Russian]

Davidova, S.S. (2014). Osobenosti lecheniya arterialnoy gipertonii u muzhchin s opucholyu pochki posle laparoskopicheskoy nefrektomii [Features of the treatment of arterial hypertension in men with kidney tumor after laparoscopic nephrectomy]. Arkhiv vnutreney meditsyny – Archieve of Internal Medicine, 2 (16), 42 [in Russian].

Stachovskyy, E.O. (2016).Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi, tretynnoi (vysokospetsializovanoi). Rak nyrky [Unified clinical protocol of primary, secondary, specialized, tertiary (highly specialized) care]. Kyiv [in Ukrainian].

Mindikoglu, A.L., & Pappas, S.C. (2018). New developments in hepatorenal syndrome. Clin. Gastroenterol. Hepatol., 16 (2), 162-177. DOI: 10.1016/j.cgh.2017.05.041.

Pirig, L.A. (2016). Orhanizatsiia medychnoi dopomohy v Ukraini: suchasnyi stan i perspektyvy [Organization of nephrological care in Ukraine: current status and prospects]. Pochki – Kidneys, 4 (18). DOI: https://doi.org/10.22141/2307-1257.4.18.2016.84319 [in Ukrainian]. DOI: https://doi.org/10.22141/2307-1257.4.18.2016.84319

Caravaca-Fontán, F., Azevedo, L., Luna, E., Caravaca, F. (2017). Patterns of progression of chronic kidney disease at later stages. Clin. Kidney J., 11 (2), 246-253. DOI: 10.1093/ckj/sfx083. DOI: https://doi.org/10.1093/ckj/sfx083

Voilenko, O.А., Vukalovich, P.S., Vitruk, Yu.V., Stachovskyy, E.O., & Kotov, E.O. (2013). Uskladnennia rezektsii nyrky hry operatyvnomu likuvanni khvorykh na nyrkovo- klitinnyi rak [Complications of kidney resection in the surgical treatment of patients with renal cell carcinoma]. Klinichna onkolohiia – Clinical Oncology, 9 (1), 1-4 [in Ukrainian].

Mindikoglu, A.L., & Pappas, S.C. (2018). New developments in hepatorenal syndrome. Clin. Gastroenterol. Hepatol., 16 (2),162-177. DOI: 10.1016/j.cgh.2017.05.041. DOI: https://doi.org/10.1016/j.cgh.2017.05.041

Braam, B., Joles, J.A., Danishwar, A.H., & Gaillard, C.A. (2014). Cardiorenal syndrome-current understanding and future perspectives. Nat. Rev. Nephrol., 10 (1), 48-55. DOI: 10.1038/nrneph. 2013.250.

Perazella, M.A. (2009). Renal vulnerability to drug toxicity. CJASN. 4 (7), 1275-1283. DOI: 10.2215 / CJN.020309 DOI: https://doi.org/10.2215/CJN.02050309

Filipets, N.D., Ivanov, D.D., & Hozhenko, A.I. (2019). Blokatory renin- anhiotenzyn-aldosteronovoi systemy yak osnovnyi patohenetychnyi napriam medykamentoznoi nefroprotektsii [Renin-angiotesin-aldosterone system blockers as the main pathogenetic direction of drug nephroprotection]. Pochky – Kidneys, 8 (1), 34-39 [in Ukrainian].

Hozhenko, A.I., Kuznetsova, E. S., & Kuznetsova, E.N. (2015). Funktsionalnyy pochechnyy rezerv u bolnykh s sakharnym diabetom 2 tipa s khronicheskoy boleznyu pochek [Functional renal reserve in patients with type 2 diabetes mellitus and chronic kidney disease]. Nephrologiya – Nephrology, 19 (4), 95-99 [in Russian]. Retrieved from: https://journal.nephrolog.ru/jour/article/view/115/0. [in Russian].

Ivanov, D.D. (2016). Central hemodynamics and drugs of choice for the correction of hypertension in chronic kidney disease. Počki, 1 (15). Retrieved from: https://doi.org/10.22141/2307-1257.1.15.2016.71468. DOI: https://doi.org/10.22141/2307-1257.1.15.2016.71468

Giuseppe Mancia, & Guy De Backer (2007). Rekomenda­tsii z diahnostyky ta likuvannia arterialnoi hipertenzii 2007 roku. Robocha hrupa z diahnostyky ta likuvannia arterialnoi hipertenzii Yevropeiskoho tovarystva z hipertenzii (ESН) і Yevropeiskoho kardiolohichnoho tovarystva (ESC) [Working Party on the Diag­nosis and Treatment of Hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)]. Journal of Hypertension, 25, 1005-1187 [in Ukrainian].

Downloads

Published

2020-10-26

How to Cite

Pasichnyk S. М., Pasichnyk М. S., Leschuk О. B., & Gozhenko А. І. (2020). Postoperative prevention of chronic kidney disease in patients with renal cell Carcinoma. Hospital Surgery. Journal Named by L.Ya. Kovalchuk, (3), 77–81. https://doi.org/10.11603/2414-4533.2020.3.11465

Issue

No. 3 (2020)

Section

EXPERIENCE OF WORK

License

Authors who publish their work in Hospital Surgery. Journal by L. Ya. Kovalchuk agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).